A situation analysis of Retinopathy of Prematurity in South Africa

CHF 57.55
Auf Lager
SKU
DLAJOFSJDBK
Stock 1 Verfügbar
Geliefert zwischen Mo., 10.11.2025 und Di., 11.11.2025

Details

Retinopathy of prematurity (ROP) is a major cause of blindness in children in middle-income countries. In 1995, it accounted for 10.6% of blindness in children in schools for the blind in South Africa. This study was undertaken to estimate the number of premature babies at risk and to investigate policies, practices and screening programmes. 13000 to 15000 surviving premature babies are at risk of ROP each year. Shortage of equipment precluded continuous oxygen monitoring in public units. Nursing levels were often below recommendations, and most nurses were unaware of target oxygen saturations. Private units were well staffed and adequately equipped. Ophthalmologists were only visiting four units on a regular basis for screening, using the birth weight criterion of ,1500 g for ROP screening. ROP needing treatment rates were low (1.6 2.9%), as were rates of follow-up. Access to neonatal care is increasingly available and babies are being saved at all levels. Unless concomitant strategies are put into place for screening, Retinopathy of prematurity is likely to be a major cause of blindness.

Autorentext

Sara Varughese MSc FRSC is Program Manager Disability (regional Advisor WHO SEARO) Formerly Medical Advisor CBM South Asia Regional Office North and earlier was Consultant Ophthalmologist Dr Shroffs Charity Eye Hospital Delhi with special expertise in paediatric ophthalmology and oculoplastics

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Autor Sara Varughese
    • Titel A situation analysis of Retinopathy of Prematurity in South Africa
    • Veröffentlichung 04.08.2010
    • ISBN 3838367936
    • Format Kartonierter Einband
    • EAN 9783838367934
    • Jahr 2010
    • Größe H220mm x B150mm x T4mm
    • Untertitel Retinopathy of prematurity in South Africa: an assessment of needs, resources and requirements for screening programmes
    • Gewicht 113g
    • Genre Medizin
    • Anzahl Seiten 64
    • Herausgeber LAP LAMBERT Academic Publishing
    • GTIN 09783838367934

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470